Liver fibrosis impairs hepatic pharmacokinetics of liver transplant drugs in the rat model.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Drug Metabolism and Pharmacokinetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2133/DMPK.DMPK-10-RG-031PMID 20877138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cirrhosis: caring for patients with end-stage liver failure.

  2008cited by this paper
• A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation

  2007cited by this paper
• Treatment of cirrhotic ascites.

  2007cited by this paper
• The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes.

  2004cited by this paper
• Quantitative evaluation of altered hepatic spaces and membrane transport in fibrotic rat liver

  2002cited by this paper
• Enterohepatic Circulation

  2002cited by this paper
• Omeprozole Therapy in Pediatric Patients After Liver and Intestinal Transplantation

  2002cited by this paper
• Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug.

  2002cited by this paper
• Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process.

  2001cited by this paper
• Functional Impairment of Sinusoidal Membrane Transport of Organic Cations in Rats with CCl4-Induced Hepatic Failure

  2000cited by this paper
• Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver

  2000cited by this paper
• Commentary: using the convection-dispersion model and transit time density functions in the analysis of organ distribution kinetics.

  2000cited by this paper
• Modeling of Hepatic Elimination and Organ Distribution Kinetics with the Extended Convection-Dispersion Model

  1999cited by this paper
• The risk of surgery in patients with liver disease

  1999cited by this paper
• Kinetic analysis of vascular marker distribution in perfused rat livers after regeneration following partial hepatectomy.

  1998cited by this paper
• Drug Administration in Chronic Liver Disease

  1997cited by this paper
• On the validity of the dispersion model of hepatic drug elimination when intravascular transit time densities are long-tailed.

  1997cited by this paper
• An optimized model for rat liver perfusion studies.

  1996cited by this paper
• Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver.

  1996cited by this paper
• Drug metabolism in liver disease: implications for therapeutic drug monitoring.

  1996cited by this paper
• Sulfation of acetaminophen by the perfused rat liver: The effect of red blood cell carriage

  1995cited by this paper
• Liver regeneration and the effect of exogenous putrescine on regenerative activity after partial hepatectomy in cirrhotic rats

  1992cited by this paper
• Clinical Pharmacokinetics in Patients with Liver Disease

  1991cited by this paper
• Guide to Drug Dosage in Hepatic Disease

  1988cited by this paper
• A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations

  1986cited by this paper
• Hepatic microcirculation in the perfused cirrhotic rat liver.

  1985cited by this paper
• Hepatic circulation in cirrhosis.

  1985cited by this paper
• Metoprolol in portal hypertension

  1982cited by this paper
• High yield micronodular cirrhosis in the rat.

  1982cited by this paper
• Altered gentamicin distribution in ascitic patients.

  1979cited by this paper
• [Treatment of cirrhotic ascites].

  1979cited by this paper
• A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.

  1976cited by this paper

• Intervention mechanism of marine-based chito-oligosaccharide on acute liver injury induced by AFB1 in rats

  2024cites this paper
• New Insights Into the Persistent Effects of Acute Exposure to AFB1 on Rat Liver

  2022cites this paper
• A Pilot Study of the Maternal‐Fetal Pharmacokinetics of Furosemide in Plasma, Urine, and Amniotic Fluid of Hypertensive Parturient Women Under Cesarean Section

  2020cites this paper
• Multiphoton microscopy and fluorescence lifetime imaging provide a novel method in studying drug distribution and metabolism in the rat liver in vivo.

  2011cites this paper